United States set
language
Menu Shopping cart $0 Search
Manufactured by BioVendor

Human sST2 ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA
  • Other names:Soluble suppression of tumorigenicity 2, soluble ST2, Receptor for interleukin-33, Interleukin 1 receptor-like 1, IL1RL1, sST-2, soluble ST2, RI IL-33
  • Species:Human
United States orders are shipped from our US branch, BioVendor, LLC
Cat. No. Size Price


RBL031R 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Sandwich ELISA

Applications

Serum, Plasma

Sample Requirements

10 µl/well

Shipping

Shipped on blue ice packs. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, all components are stable until the expiration date (see label on the box).

Calibration Range

0.1875 - 6 ng/ml

Limit of Detection

20 pg/ml

Intra-assay (Within-Run)

CV =6.9%

Inter-assay (Run-to-Run)

CV =12.9%

Spiking Recovery

113%

Dilution Linearity

96%

Summary

Features

  • It is intended for research use only
  • The total assay time is less than 2.5 hours
  • The kit measures specifically human sST2
  • Assay format is 96 wells
  • Standard is a recombinant protein
  • Components of the kit are provided ready to use, concentrated or dried

Research topic

Cardiovascular disease, Coronary artery disease

Summary

sST2 (Soluble suppression of tumorigenicity 2) is a member of the interleukin-1 receptor family. Like other members of the IL-1 family, the binding of IL-33 to its transmembrane receptor ST2L on the surface of inflammatory cells activates intracellular signaling pathways and mediates pro-inflammatory effects. The soluble ST2 isoform is released by activated Th2 cells and stressed cardiac myocytes and is elevated in the serum of patients with allergic asthma. Soluble ST2 acts as a decoy receptor, blocking IL‑33’s ability to signal through the transmembrane ST2 receptor. sST2 is a strong predictor of disease severity and mortality in cardiovascular disease and serves as a reliable predictor of mortality in patients with stable coronary artery disease and chronic heart failure.

Related Products Docs

Find documents for the lot

Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít